// App-Quantinova.ai

e15512 : Identifying targetable genetic alterations in advanced gastric cancer through broad, hybrid capture-based next generation sequencing.

Researchers

Presenter

  • Dong Liu

Principal Investigators

  • Helei Hou

  • Chuantao Zhang

  • Na Zhou

  • Congmin Liu

  • Yurong Niu

  • Tianjun Li

  • Jinping Zhang

  • Zhuokun Li

  • Xiaonan Yang

  • Yonghui Xie

  • Xiaochun Zhang

Medical Centers

  • The Affiliated Hospital of Qingdao University, Qingdao, China

  • Qingdao Municipal Hospital, Qingdao University, Qingdao, China

  • The University of Texas MD Anderson Cancer Canter, Houston, TX

  • Beijing Genomics Institute (BGI)-Tianjin, Tianjin, China

Locations

  • United States

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Gastric Cancer

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved